Castellanos RR, Ferrer HI, Segura PLA, Ojeda MMR, Fernández RD

Language: Spanish
References: 28
Page: 667-679
PDF size: 185.10 Kb.

ABSTRACT

Background: young patients with acute myocardial infarction are a special challenge for health systems because of the deep repercussion that it causes from the psychological and economic points of view.
Objective: to present the cases of three patients younger that 45 years old with acute myocardial infarction, as well as the cardiovascular risks that were founded.
Clinical case: case 1 A forty-two-year-old male patient with a history of high blood pressure that started with a precordial pain of two days of evolution and moderate intensity that appeared when making moderate physical effort. The pain intensified so the patient came to the emergency room. Case 2 A thirty-seven-year-old male patient with a history of non-treated high blood pressure, obesity, smoking habits and high levels of triglycerides came to the emergency room with precordial pain that appeared suddenly after making an intense physical effort. The pain spread to the neck, jaw and left arm; the patient also presented perspiration, coldness and felt like dying. Case 3 A thirty-eight-year-old female patient with a history of type two diabetes mellitus and high blood pressure that after going to the consultation of the family physician and to the consultation of the internist presenting precordial pain is sent to the consultation of cardiology with the same diagnosis for being studied.
Conclusions: high blood pressure, dyslipidemia, type two diabetes mellitus and obesity were detected as risk factors, along with the family history of first order of cardiopathy in patients younger than 50 years old.

REFERENCES

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551-67.

2. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):12-20.

3. Fernandez-Jimenez R, Lopez-Romero P, Suarez-Barrientos A, Garcia-Rubira JC, Fernandez-Ortiz A, Fuster V, et al. Troponin release overestimates infarct size in presence of left ventricular hypertrophy. J Am Coll Cardiol. 2012;60(7):640-1.

4. Fernández-Ortiz A, Pan M, Aros F, Barrabés JA, Bodí V, Cequier A, et al. Comentarios a la guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología. Rev Esp Cardiol. 2012;65(2):125-30.

5. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009 Aug 27;361(9):858-67.

6. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol. 2010;55(19):2118-24.

7. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010 Apr;31(8):943-957.

8. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011 Jan;124(1):40-7.

9. Parakh K, Thombs BD, Bhat U, Fauerbach JA, Bush DE, Ziegelstein RC. Long-term significance of Killip class and left ventricular systolic dysfunction. Am J Med. 2008 Nov;121(11):1015-58. 677

10. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, et al. Acute myocardial infarction in the young- The University of Michigan experience. Am Heart J. 2002;143(1):56-62

11. Ranjith N, Pegoraro RJ, Naidoo DP. Demographic data and outcome of acute coronary syndrome in the South African Asian Indian population. Cardiovasc J S Afr. 2005 Jan-Feb;16(1):48-54.

12. Jiang SL, Ji XP, Wang Y, Wang XR, Ni M, Zhang C, et al. Impact of gender on in-hospital death in hospitalized patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Jul;36(7):590-3.

13. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, et al. Rivaroxaban in Patients with a Recent Acute Coronary Syndrome. N Engl J Med. 2012 Jan 5;366(1):9-19.

14. Freixa X, Bellera N, Ortiz-Perez JT, Jiménez M, Pare C, Bosch X, et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J. 2012 Jan;33(1):103-12.

15. Pinto DS, Frederick PD, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of on site fibrinolytic declines as delays increase. Circulation. 2011 Dec 6;124(23):2512-21.

16. Vlaar PJ, Mahmoud KD, Holmes DR, van Valkenhoef G, Hillege HL, van der Horst IC, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011 Aug 9;58(7):692-703.

17. Cannon CP, Braunwald E. Unstable angina and non-ST segment elevation myocardial infaction. In: Libby P, Bonow RO, Mann DL, Zipes DP, Braunwald E, editors. Braunwald’s heart disease. 8th. Philadelphia: Saunders; 2008. p. 1319-51.

18. De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, et al. Drugeluting vs bare-metal stents in primary angioplasty: a pooled patient-level metaanalysis of randomized trials. Arch Intern Med. 2012 Apr;172(8):611-21.

19. García-Porrero E, Andrés-Esteban E, de Pablo-Zarzosa C, León-Latre M. Cardiología preventiva y rehabilitación. Rev Esp Cardiol. 2010;63(Suppl 1):40-8.

20. Badimón L, Vilahur G, Padró T. Lipoproteínas, plaquetas y aterotrombosis. Rev Esp Cardiol. 2009;62(10):1161-78.

21. Badimón JJ, Ibáñez B. Incremento de las HDL como arma terapéutica en la aterotrombosis. Rev Esp Cardiol. 2010;63(3):323-33. 678

22. Truong QA, Bayley J, Hoffmann U, Bamberg F, Schlett CL, Nagurney JT, et al. Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: from the «Rule Out Myocardial Infarction using Computer Assisted Tomography» (ROMICAT) trial. Am HeartJ. 2012 Jun;163(9):972-9.

23. Fernández-Jiménez R, Fernández-Ortiz A. Panel multimarcador para pacientes com dolor torácico: ¿está todo dicho. Rev Esp Cardiol. 2013 Jul;66(7):523-5.

24. SK, Kilhamn J, Steg PG, Harrington RA, Wallentin L. Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes with Clopidogrel and Ticagrelor: Insights from the platelet inhibition and patient outcomes trial. Circulation. 2012 Feb 28;125 (8):978-86.

25. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jul;33(14):1787-847.

26. Sanchis J, Bardají A, Bosch X, Loma Osorio P, Marín F, Sánchez PL, et al. Fracción aminoterminal del propéptido natriurético cerebral y troponina ultrasensible en el dolor torácico agudo de origen incierto. Un subestudio del estudio PITÁGORAS. Rev Esp Cardiol. 2013 Jul;66(7):532-8.

27. Croymans DM, Barth JD, Roberts CK. Carotid intima-media thickness, dietary intake, and cardiovascular phenotypes in adolescents: relation to metabolic syndrome. Metabolism. 2010 Abr;59(4):533-9.

28. Melki D, Lind S, Agewall S, Jernberg T. Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation. Clin Chim Acta. 2012 May 18;413 (9-10):933-7.